MYLAN INSTITUTIONAL FDA Approval ANDA 205239

ANDA 205239

MYLAN INSTITUTIONAL

FDA Drug Application

Application #205239

Documents

Label2016-03-04
Letter2016-02-22

Application Sponsors

ANDA 205239MYLAN INSTITUTIONAL

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION20MG/VIAL0DANTROLENE SODIUMDANTROLENE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2016-02-18STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205239
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"DANTROLENE SODIUM","activeIngredients":"DANTROLENE SODIUM","strength":"20MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"02\/18\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205239Orig1s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"02\/18\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205239Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205239Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2016-02-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.